2122 / 2894
2122
Anestesia por subespecialidades en el adulto
IV
78. Arnon S, Schechter R, Inglesby T, et al: Botulinum
toxin as a biological weapon. JAMA 285:1059, 2001.
79. Stalberg E, Trontlj JV: Single Fiber Electromyography:
Studies in Healthy and Diseased Muscle, 2nd ed.
New York, Raven Press, 1994.
80. Lederberg J (ed): Biological Weapons: Limiting the
Threat. London, MIT Press, 1999.
81. Watters MR: Organic neurotoxins in seafoods. Clin
Neurol Neurosurg 97:119, 1995.
82. Benton BJ, Rivera VR, Hewetson JF, Chang FC: Rever-
sal of saxitoxin-induced cardiorespiratory failure by a
burro-raised alpha-STX antibody and oxygen therapy.
Toxicol Appl Pharmacol 124:39, 1994.
83. Lemley PV, Thalley BS, Stafford DC: Prophylactic and
therapeutic efficacy of an avian antitoxin in ricin
intoxication. Ther Immunol 2:59, 1995.
84. Wax PM, Becker CE, Curry SC: Unexpected gas
casualties in Moscow: A medical toxicological pers-
pective. Ann Emerg Med 41:700–705, 2003.
85. Leppla SH: Anthrax toxin edema factor: A bacterial
adenylate cyclase that increases cyclic AMP concen-
trations in eukaryotic cells. Proc Natl Acad Sci USA
79:3162–3166, 1982.
86. O’Brien J, Friedlander A, Dreier T, et al: Effects of
anthrax toxin components on human neutrophils.
Infect Immunol 47: 3016-3010, 1985.
87. Centers for Disease Control and Prevention: Biote-
rrorism alleging use of anthrax and interim guidelines
for management. MMWR Morb Mortal Wkly Rep
48:69, 1999.
88. Butler T:
Yersinia
species including plague.
In
Mandell
GL, Bennett JE, Dolin R (eds): Principles and Practice
of Infectious Diseases, 5th ed. Philadelphia, Churchill
Livingstone, 2000, p 2406.
89. McGovern TW, Friedlander AM: Plague.
In:
Textbook
of Military Medicine: Medical Aspects of Chemical,
BiologicalWarfare.Washington,DC,U.S.Department
of the Army, 1997, p 479.
90. Ca
rpenterCCJ:Cholera.In
WeatherallDJ,Ledingham
JGG, Warrell DA (eds): Oxford Textbook of Medicine,
2nd ed. Oxford, UK, Oxford University Press, 1987,
p 231.
91. Centers for Disease Control and Prevention: Labora-
tory acquired human glanders—Maryland. MMWR
Morb Mortal Wkly Rep 49:532, 2000.
92. McGovern TW, Christopher GW, Eitsen EM: Cuta-
neous manifestations of biological warfare and related
threat agents. Arch Dermatol 135:311, 1999.
93. Moles TM: Emergency medical services systems and
HAZMAT major incidents. Resuscitation 42:103,
1999.
94. Baker DJ: Management of respiratory failure in toxic
disasters. Resuscitation 42:125, 1999.
95. Baker DJ: Advanced life support for acute toxic injury
(TOXALS). Eur J Emerg Med 3:256–262, 1996.
96. de Bleeker JL: The intermediate syndrome in organo-
phosphate poisoning: An overview of experimental
and clinical observations. J Toxicol Clin Toxicol
33:683–686, 1995.
97. Karalliedde L, Baker DJ, Marrs T: Organophosphate-
induced intermediate syndrome: Etiology and rela-
tionships with myopathy. Toxicol Rev 25:1–14,
2006.